A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide

Archives of General Psychiatry

Volumn 57, Issue 8, 2000, Pages 729-738

  Mann, J John ^a,b   Huang, Yung Yu ^a   Underwood, Mark D ^a   Kassir, Suham A ^a   Oppenheim, Sara ^a   Kelly, Thomas M ^a   Dwork, Andrew J ^a   Arango, Victoria ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b New York State Psychiatric Institute ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIANOPRAMINE; DNA; SEROTONIN TRANSPORTER; TRITIUM;

ADULT; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PREFRONTAL CORTEX; PROMOTER REGION; RECEPTOR BINDING; SEROTONINERGIC SYSTEM; SUICIDE;

EID: 0033838035     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.57.8.729     Document Type: Article

References (125)

1. CSF monoamine metabolites in melancholia
2. 5-Hydroxytryptamine metabolites in affective illness: The effect of tryptophan administration
3. CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls
4. CSF and urinary biogenic amines and metabolism in depression and mania: A controlled univariate analysis
5. Biogenic amine metabolites in cerebrospinal fluid of depressed and manic patients
6. Cerebrospihal fluid amine metabolites
7. Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia
8. Central serotonin metabolism and frequency of depression
9. 5-Hydroxyindolacetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis
10. Changes on recovery in the concentrations of tryptophan and the biogenic amine metabolites in the cerebrospinal fluid of patients with affective illness
11. Brain research mechanisms and symptom formation: Estimation of brain amine metabolism in affective illness: Cerebrospinal fluid studies utilizing probenecid
12. Lumbar CSF 5-hydroxyindoleacetic acid and homovanillic acid in affective syndromes
13. Catecholamine metabolite studies in the affective disorders: Issues of specificity and significance
14. Blunted growth hormone and prolactin responses to L-tryptophan in depression: A state-dependent abnormality
15. Serotonergic studies in patients with affective and personality disorders: Correlates with suicidal and impulsive aggressive behavior
16. Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients
17. Prolactin and cortisol responses to d-fenfluramine in major depression: Evidence for diminished responsivity of central serotonergic function
18. Plasma prolactin changes following fenfluramine in depressed patients compared to controls: An evaluation of central serotonergic responsivity in depression
19. Serotonergic function in depression: Prolactin response to intravenous tryptophan in depressed patients and healthy subjects
20. Serotonin function and depression: Neuroendocrine and mood responses to intravenous L-tryptophan in depressed patients and healthy comparison subjects
21. Effect of amitriptyline on endocrine responses to intravenous L-tryptophan
22. Therapeutic effects of serotonin uptake inhibitors in depression
23. Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients
24. Serotonin function and the mechanism of antidepressant action: Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan
25. Recovery from major depression is not associated with normalization of serotonergic function
26. Cerebrospinal fluid studies in suicide: An overview
27. CSF 5-HIAA predicts suicide risk after attempted suicide
28. Prediction of suic dal behavior from biologic tests
29. Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients: A 5-year follow-up study
30. Serotonin chemistry in the brain of suicide victims
31. High affinity binding of antidepressants to a biogenic amine transport site in human brain and platelet: Studies in depression
32. Reversed hemispheric asymmetry of imipramine binding in suicide victims
33. Serotonergic split brain and suicide
34. Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides
35. Tritiated imipramine binding sites are decreased in the frontal cortex of suicides
36. Human brain receptor alterations in suicide victims
37. 3H-imipramine binding in the frontal cortex of suicides
38. 3H-imipramine binding: Studies in the frontal cortex of normal controls and suicide victims
39. Serotonergic mechanisms in brains of suicide victims
40. 3H-paroxetine binding in cerebral cortex of suicide victims is partly due to fewer high-affinity, non-transporter sites
41. Selective abnormalities of prefrontal serotonergic receptors in schizophrenia: A postmortem study
42. 3H-paroxetine binding sites in postmortem human brain from controls and suicides
43. 3H]paroxetine, in antidepressant-free depressed suicides
44. Evidence for the 5-HT hypothesis of suicide: A review of post-mortem studies
45. Relevance of serotonergic postmortem studies to suicidal behavior
46. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims
47. Psychobiology of suicidal behavior
48. The neurobiology of suicide: From the bench to the clinic
49. Serotonin and major depression
50. The neurobiology of suicide
51. Role of serotonin in the pathophysiology of depression: Focus on the serotonin transporter
52. Genetics
53. Attempted suicide among living co-twins of twin suicide victims
54. Genetic and biologic risk factors for suicide in depressive disorders
55. Stability of interindividual differences in serotonin function and its relationship to severe aggression and competent social behavior in rhesus macaque females
56. Possible association of a polymorphism of the tryptophan hydroxylase gene with suicidal behavior in depressed patients
57. Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms: Relationships to monoamine metaborite concentrations in CSF of healthy volunteers
58. A tryptophan hydroxylase gene marker for suicidality and alcoholism
59. Aggression and anger-related traits associated with a polymorphism of the tryptophan hydroxylase gene
60. Decreased imipramine binding in the brains of patients with depressive illness
61. 123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography
62. Hostility and depression associated with suicide attempts
63. Early-onset substance abuse and community violence by outpatients with chronic mental illness
64. Violence and aggression
65. Factor analysis of some psychometric measures of impulsiveness and anxiety
66. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region
67. Genetic linkage study of bipolar disorder and the serotonin transporter
68. Serotonin transporter gene polymorphisms: Ethnic difference and possible association with bipolar affective disorder
69. Association studies of bipolar disorder at the human serotonin transporter gene (hSERT;5HTT)
70. A novel functional polymorphism within the promoter of the serotonin transporter gene: Possible role in susceptibility to affective disorders
71. Role of serotonin transporter promoter repeat length polymorphism (5-HTTLPR) in seasonal affective disorder
72. Towards a clinical model of suicidal behavior in psychiatric patients
73. The neuropharmacology of serotonin
74. Association analysis of a regulatory variation of the serotonin transporter gene with severe alcohol dependence
75. Selective genotyping for the role of 5-HT(2A), 5-HT(2C), and GABA(α6) receptors and the serotonin transporter in the level of response to alcohol: A pilot study
76. Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African-and European-American and Japanese populations and in alcohol-dependent subjects
77. No association between the serotonin transporter gene regulatory region polymorphism and the Tridimensional Personality Questionnaire (TPQ) temperament of harm avoidance
78. The serotonin transporter gene and peer-rated neuroticism
79. Validity of DSM-III-R diagnosis by psychological autopsy: A comparison with antemortem diagnosis
80. 2 and β-adrenergic receptor binding sites in the brain of suicide victims
81. 3H-cyanoimipramine
82. Relationship of psychopathology to the human serotonin 1B genotype and receptor binding kinetics in post-mortem brain tissue
83. Postmortem neurochemical studies in depression
84. 2 sites in cortex and amygdala
85. Frequency of long allele in serotonin transporter gene is increased in depressed suicide victims
86. Autoradiographic analysis of tritiated imipramine binding in the human brain post mortem: Effects of suicide
87. The domain of supervisory processes and temporal organization of behaviour
88. The return of Phineas Gage: Clues about the brain from the skull of a famous patient
89. Serotonin transporter gene (HTTLPR) is not in linkage disequilibrium with prepubertal and early adolescent bipolarity
90. Analysis and mete-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders
91. Association analysis of the 5-HT2C receptor and 5-HT transporter genes in bipolar disorder
92. Serotonin transporter gene and risk for bipolar affective disorder: An association study in a Spanish population
93. Serotonin transporter (5-HTT) gene polymorphisms are not associated with susceptibility to mood disorders
94. Serotonin transporter candidate gene studies in affective disorders and personality: Promises and potential pitfalls
95. A functional variant of the serotonin transporter gene in families with bipolar affective disorder
96. Genetic association analysis of serotonin system genes in bipolar affective disorder
97. Bipolar disorder and the serotonin transporter gene: A family-based association study
98. Effects of serotonin transporter promoter genotype on platelet serotonin transporter functionality in depressed children and adolescents
99. Adrenocortical hyperactivity in depression: Effects of agitation, delusions, melancholia, and other illness variables
100. Urinary free cortisol excretion in depression
101. Cortisol production in depressive illness
102. 2 receptor binding and 5-HT transporter mRNA expression in rat brain
103. Alternative splicing of the human serotonin transporter gene
104. Systematic screening for mutations in the coding region of the human serotonin transporter (5-HTT) gene using PCR and DGGE
105. Functional analysis of a novel human serotonin transporter gene promoter in immortalized raphe cells
106. Serotonin transporter gene is not associated with symptomatology of schizophrenia
107. Serotonin transporter gene not associated with psychotic symptomatology of mood disorders
108. 3H-paroxetine platelet binding before and after sertraline
109. Serotonin transporter (SERT) mRNA and binding site densities in male rat brain affected by sex steroids
110. Estradiol-17β increases serotonin transporter (SERT) mRNA levels and the density of SERT-binding sites in female rat brain
111. Sex steroid control of mood, mental state and memory
112. Abnormal expression of serotonin transporter mRNA in the frontal and temporal cortex of schizophrenics
113. Cross-national epidemiology of major depression and bipolar disorder
114. Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level
115. Further studies on platelet serotonin transporter binding in depression
116. Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from non-impulsive violent behavior
117. A prospective follow-up study of alcoholic violent offenders and fire setters
118. Relationship of psychobiological variables to recidivism in violent offenders and impulsive fire setters: A follow-up study
119. Cerebrospinal fluid monoamine metabolites levels in male arsonists
120. Alcohol and central serotonin metabolism in man
121. Single-photon emission tomography imaging of monoamine transporters in impulsive violent behaviour
122. Reduced central serotonin transporters in alcoholism
123. Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels
124. Tryptophan depletion and depressive vulnerability
125. Low brain serotonin turn-over rate (low CSF 5-HIAA) and impulsive violence